Dr. Antoinette Maassen van den Brink wins the VNVA Corrie Hermannprice
Dr. Antoinette Maassen van den Brink will receive the VNVA (Vereniging Nederlandse Vrouwelijke Artsen) Corrie Hermannprice on the 2nd of October 2021, for her role as pioneer in the research area of migraine and female hormones. Read the full article here (in Dutch).
Newspaper: women respond different to medication
Men and women respond different to medication. Researchers from the Leiden University Medical Center and Erasmus MC discovered that triptans are a good example. Women experience more side effects, for example. Nevertheless, they are prescribed the same dosage as men. Read the full article here (in Dutch).
RADAR+ Interview with prof. dr. Terwindt
Two million Dutch people suffer from migraine, women twice as often as men. Acute medication is less effective in women. Prof. dr. Terwindt from the LUMC: ‘Women with migraine have the right to better answers’. Read the full article here (in Dutch).
Less benefits, more side effects
Women benefit less from triptans – migraine drugs – than men. In addition, women more often suffer from side effects. This was demonstrated in a study by the LUMC and Erasmus MC. Read more in this interview in Leidsch Dagblad (in Dutch).
Can migraine patients benefit from the oral contraceptive pill?
Each month WOMEN Inc. asks a researcher 5 questions. This month: Antoinette Maassen van den Brink, farmacologist and researcher from the Erasmus MC, about her research on the relationship between hormones and migraine. Read the full article here (in Dutch).
Women respond differently to treatment of migraine with triptans than men
Headache researchers from the Leiden University Medical Center (LUMC) and the Erasmus Medical Center (Erasmus MC) concluded that women more often experience headache recurrences after the intake op triptans and report more side effects. The results have been published in the journal Neurology. See for the full article the LUMC website.
News article in Nature: Closing the gender gap in migraine research
“Terwindt notes that many general practitioners remain unaware of the aura-associated risk of stroke, and prescribe oral contraception as a stabilizing treatment for migraine without full knowledge of the risks or clear evidence of the benefits. “It’s just trial and error,” she says. She and Maassen van den Brink have launched a study to establish more firmly whether hormonal treatment helps manage migraine.” Read the full article here.
Women with migraine are more jealous and suffer from cold feet more often
Hoofdpijnonderzoekers uit het Leids Universitair Medisch Centrum (LUMC) en het (Erasmus MC) trekken deze conclusie in twee nieuwe studies naar de effecten van migraine. De resultaten zijn gepubliceerd in de tijdschriften Journal of Headache and Pain en European Journal of Neurology. Zie ook de berichtgeving hierover op BNR Nieuwsradio, de Telegraaf en het AD.
NPO Focus TV Orkaan in je hoofd
During this episode of Focus about migraine dr. Terwindt explains that little research has been done addressing the role of hormones in migraine. Click here to see the full episode (in Dutch).
Hersenstichting Publieksdag: Migraine & Prikkels
Dr. Terwindt talks about migraine and triggers provoking attacks during the yearly Hersenstichting Publieksdag. Click here to see the full video (in Dutch).
In 2015 dr. Maassen van den Brink received the Migraine and Women’s Health Research Award of the American Headache Society. Why is her research so important and what is her advice for women with migraine? Read more (in Dutch).